# K161126: ASAHI Corsair Pro

- Pathway: 510(k) (Traditional)
- Applicant: Asahi Intecc Co., Ltd.
- Decided: Aug 25, 2016 after 126 days
- Product code: DQY (Catheter, Percutaneous)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K001992 (2000). 15 ancestors in all.
11 later devices descend from it; 2 cite it directly.
0 of 27 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K151103: ASAHI Corsair Microcatheter, Asahi Intecc Co., Ltd. (2015) Summary page 4.
- K083127: Asahi Corsair Microcatheter, Asahi Intecc Co., Ltd. (2009) Summary page 4.

## Most influential descendants
- K171933: ASAHI PTCA Guide Wires, ASAHI Corsair Microcatheter, ASAHI Corsair Pro Microcatheter (2018), 7 descendants of its own
- K182360: Teleport Microcatheter (2018), 2 descendants of its own
- K231608: Teleport XT Microcatheter (2024), 1 descendant of its own
- K212211: Turnpike catheter, Turnpike Spiral catheter, Turnpike LP catheter, Turnpike Gold catheter, GuideLiner V3 catheter, TrapLiner catheter (2022), 1 descendant of its own
- K242588: COREPASS Modular Microcatheter (FLEX); COREPASS Modular Microcatheter (CONTROL) (2025), 0 descendants of its own

## Indications for use
The ASAHI Corsair Pro is intended to provide support to facilitate the placement of guide wires in the coronary and peripheral vasculature and can be used to exchange one guide wire for another. The ASAHI Corsair Pro is also intended to assist in the delivery of contrast media into the coronary, peripheral, and abdominal vasculature. This device should not be used in neurovasculature.

Source page: https://510kreport.com/device/K161126
Methodology: https://510kreport.com/methodology